Mycartis

Provider of bio-marker discovery platform for immunodiagnostics

placeGhent, Flanders, Belgium calendar_todayFounded 2006 groups2 employees language mycartis.net

Registered entities

Innovation

25 patent families (23 granted) — focus: Physics & computing, Operations & transport, Chemistry & metallurgy, Electricity & electronics; filing pace dormant. Cited 553 times.

YearFilings
20144
201514
201616
201713
20187
20194
20204

Investor mix

6 investors on record; lead investors include Valiance Asset Management; 1 has since exited.

Investor typeCountShare
Venture capital233%
Private equity233%
Other / undisclosed233%
Coming soon